Worldwide Practice Patterns in Lynch Syndrome Diagnosis and Management, Based on Data From the International Mismatch Repair Consortium
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 16 (12) , 1901-1910.e11
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trialsThe Lancet, 2012
- Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trialThe Lancet, 2011
- The PREMM1,2,6 Model Predicts Risk of MLH1, MSH2, and MSH6 Germline Mutations Based on Cancer HistoryGastroenterology, 2011
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trialsThe Lancet, 2010
- Prevalence and Predictors of Appropriate Colorectal Cancer Surveillance in Lynch SyndromeAmerican Journal of Gastroenterology, 2010
- Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relativesGenetics in Medicine, 2009
- Sharing Genetic Test Results in Lynch Syndrome: Communication With Close and Distant RelativesClinical Gastroenterology and Hepatology, 2008
- Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studiesThe Lancet, 2007
- Prediction of Germline Mutations and Cancer Risk in the Lynch SyndromeJAMA, 2006
- The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)Diseases of the Colon & Rectum, 1991